Compared with traditional drug therapy, nanomedicines exhibit intriguing biological features
to increase therapeutic efficiency, reduce toxicity and achieve targeting delivery. This review …

Vaccines have proven effective in the treatment and prevention of numerous diseases.
However, traditional attenuated and inactivated vaccines suffer from certain drawbacks such …

Despite past extensive studies, the mechanisms underlying pulmonary fibrosis (PF) still
remain poorly understood. Here, we demonstrated that lungs originating from different types …

The emergence of novel respiratory infections (eg, COVID-19) and expeditious development
of nanoparticle-based COVID-19 vaccines have recently reignited considerable interest in …

Aim: To formulate an aerosolized nanoliposomal carrier for remdesivir (AL-Rem) against
coronavirus disease 2019. Methods: AL-Rem was prepared using modified hydration …

Oxidative stress is intensely involved in enhancing the severity of various chronic respiratory
diseases (CRDs) including asthma, chronic obstructive pulmonary disease (COPD) …

Protein-based nanoparticles have garnered significant attention in theranostic applications
due to their superior biocompatibility, exceptional biodegradability and ease of functionality …

The aim of this study is to formulate and optimize novel transfersome formulations for
pulmonary drug delivery. Transfersome formulations (F1–F18) were prepared by a thin-film …

In recent years, the continuous occurrence of multi-drug resistance in the clinic has made
people pay more attention to the transporter. Changes in the expression and activity of …

Pulmonary drug delivery via aerosolization is a non-intrusive method for achieving localized
and systemic effects. The aim of this study was to establish the impact of viscosity as a novel …